The Latest Breaking News from Eli Lilly

After last week's follow-through day, investors should be looking for top stocks breaking out past new buy points.

The Dow Jones Industrial Average dropped, while the Nasdaq sold off Wednesday, as Alphabet and Microsoft dived on earnings results.

Someone with a lot of money to spend has taken a bullish stance on Eli Lilly (NYSE:LLY). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

The Dow Jones Industrial Average rose Tuesday, as Coca-Cola reported earnings results. Microsoft earnings are due out after the close.

Dow Jones futures were little changed ahead of Tuesday's open after the Dow Jones Industrial Average rallied more than 400 points Monday.

Key Takeaways: Innovent Bio has brought several drugs to market in recent years, including two announced last week, but is still losing money with no profits in sight The company has overhauled its commercialization model and is doing more licensing partnerships with multinationals to expand its drug pipeline By Molly…

A whale with a lot of money to spend has taken a noticeably bearish stance on Eli Lilly. Looking at options history for Eli Lilly (NYSE:LLY) we detected 10 strange trades.

Inflation increased more than expected in September despite the rate hikes. The stubbornly high inflation cements the case for further hawkishness from the Fed. Amid rising recession worries, we think dividend stocks Eli Lilly (LLY), APA Corporation (APA), and Bluegreen Vacations (BVH), with stable dividend-paying records, could be ideal additions…

Biogen could easily take on Roche and Eli Lilly in Alzheimer's treatment, an analyst said Thursday as he upgraded Biogen stock.

Futures pared gains as the 10-year Treasury yield in flux with big inflation reports due. The S&P 500 is at bear market lows.

Cardinal Health and Eli Lilly lead five stocks to watch. Some are holding up while others crumbled Friday amid the bear market.